Fevara plc engages in the agriculture business in the United Kingdom and internationally. The company develops, manufactures, and sells research-proven supplements, including feed licks, blocks, bagged minerals, and boluses for cattle, sheep, and horses under the following brands: Crystalyx, HorsLic, Horslyx, Scotmin Nutrition, Smartlic, Tracesure Advanced, Feed in a Drum, New Generation Supplements, Megastart, and Biosprint. It also engages in financial, property holding, and engineering activities, as well as manufactures and distributes animal health products. The company was formerly known as Carr's Group plc and changed its name to Fevara plc in September 2025. Fevara plc was founded in 1831 and is headquartered in Carlisle, United Kingdom.…
Fevara PLC (FVA) Senior Independent Director Gillian Watson to Step Down at 2027 AGM
Fevara (LON: FVA) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Packaged Foods industry, part of the Consumer Defensive sector, and reports about 201 employees.
The shares were at 143.50 GBp on 20 November 2026, up 6.7% over 52 weeks. Its 52-week range is 114.50 GBp to 160.00 GBp: the price is 10.3% below the high and 25.3% above the low.
At a market capitalisation of 74.44M GBP, it trades at 23.9 times trailing earnings and 12.8 times forward earnings. The median trailing P/E of its 18 largest Packaged Foods peers is 24.8, so FVA is valued in line with them. It pays a dividend yielding 1.68% (it pays out 41% of its earnings), against a median of 3.67% among the dividend payers in that peer group.
Fevara reports return on equity of 53.3%, an operating margin of -1.0% and flat revenue year over year.
It holds more cash than debt, a net cash position of 441.00K GBP. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 4 analysts cover the stock; their mean price target of 177.50 GBp is 23.7% above the current price.
No upcoming events tracked.